Alveolar macrophage lipid burden correlates with clinical improvement in patients with pulmonary alveolar proteinosis
Journal of Lipid Research · 2024
DOI: 10.1016/j.jlr.2024.100496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2024. Verfasst von Elinor Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, and Sleep Medicine, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles…. Hauptthemen laut MEDLINE: Pulmonary Alveolar Proteinosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, AHA.
Abstract (Originalsprache)
Pulmonary alveolar proteinosis (PAP) is a life-threatening, rare lung syndrome for which there is no cure and no approved therapies. PAP is a disease of lipid accumulation characterized by alveolar macrophage foam cell formation. While much is known about the clinical presentation, there is a paucity of information regarding temporal changes in lipids throughout the course of disease. Our objectives were to define the detailed lipid composition of alveolar macrophages in PAP patients at the time of diagnosis and during treatment. We performed comprehensive mass spectrometry to profile the lipid signature of alveolar macrophages obtained from three independent mouse models of PAP and from PAP and non-PAP patients. Additionally, we quantified changes in macrophage-associated lipids during clinical treatment of PAP patients. We found remarkable variations in lipid composition in PAP patients, which were consistent with data from three independent mouse models. Detailed lipidomic analysis revealed that the overall alveolar macrophage lipid burden inversely correlated with clinical improvement and response to therapy in PAP patients. Specifically, as PAP patients experienced clinical improvement, there was a notable decrease in the total lipid content of alveolar macrophages. This crucial observation suggests that the levels of these macrophage-associated lipids can be utilized to assess the efficacy of treatment. These findings provide valuable insights into the dysregulated lipid metabolism associated with PAP, offering the potential for lipid profiling to serve as a means of monitoring therapeutic interventions in PAP patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care, and Sleep Medicine, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medicine, David Geffen School of Medicine at…
- Department of Biological Chemistry, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, CA, USA.
- Department of Respiratory Medicine, St. Vincent's University Hospital, Dublin, Ireland; School of Medicine, University College Dublin, Dublin, Ireland.
- Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, USA.
- Department of Pediatrics, National Jewish Health, Denver, CO, USA; Department of Medicine, University of Colorado School of Medicine Aurora, CO, USA.
- Department of Medicine, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Biological Chemistry, David Geffen School of Medicine at University of Californ…
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- AHA
- American Lung Association
- NHLBI
- NIDDK
Zitieren
APA
Lee, E., Williams, K. J., McCarthy, C., Bridges, J. P., Redente, E. F., de Aguiar Vallim, T. Q., Barrington, R. A., Wang, T., & Tarling, E. J. (2024). Alveolar macrophage lipid burden correlates with clinical improvement in patients with pulmonary alveolar proteinosis. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2024.100496
Vancouver
Lee E, Williams KJ, McCarthy C, Bridges JP, Redente EF, de Aguiar Vallim TQ, et al. Alveolar macrophage lipid burden correlates with clinical improvement in patients with pulmonary alveolar proteinosis. Journal of Lipid Research. 2024. doi:10.1016/j.jlr.2024.100496
BibTeX
@article{Lee2024,
author = {Lee, Elinor and Williams, Kevin J and McCarthy, Cormac and Bridges, James P and Redente, Elizabeth F and de Aguiar Vallim, Thomas Q and Barrington, Robert A and Wang, Tisha and Tarling, Elizabeth J},
title = {Alveolar macrophage lipid burden correlates with clinical improvement in patients with pulmonary alveolar proteinosis},
journal = {Journal of Lipid Research},
year = {2024},
doi = {10.1016/j.jlr.2024.100496}
}
EUVIMED